Biotech Investing

Transparent blue cells with dark centers floating against a vibrant blue background.

Biotech and Pharma Market Update: Q1 2026 in Review

Explore Q1 biotech and pharma market trends, focusing on innovation, NIH funding and the evolving role of AI in life sciences.

Life Science Investing
Latest Articles

Top 3 Canadian Biotech Stocks in 2026

Biotech Investing

Kailera, Alamar Target Billion-Dollar Valuations in Biotech Revival

Biotech Investing

Anthropic Inks US$400 Million Deal for AI Biotech Startup Coefficient Bio

Biotech Investing

Moderna to Pay US$950 Million to Settle COVID-19 Vaccine Patent Dispute

Pharmaceutical Investing

5 Small-cap Biotech ETFs to Watch

Biotech Investing

Top 5 Small-cap Biotech Stocks

Biotech Investing
Company Profiles
LEXX

Lexaria Bioscience

Drug delivery platform innovator with multiple mainstream applications

Biotech Investing
More Companies
CEO Interviews
Badge
Cizzle Brands Corporation
A Sports Nutrition Company Leading the Next Wave in Health and Wellness
SPONSORED/ Cizzle Brands Corporation

Cizzle Brands CEO talks tariffs and strategies with health-focused product line

Biotech Investing

Sirona Biochem Eyes 2025 Launch of New Anti-aging Product

Biotech Investing

Sirona Biochem Eyes Licensing Deal for Anti-aging Compound After Clinical Trial Results

Biotech Investing
biotech News
Lexaria Bioscience (NASDAQ:LEXX)

Lexaria Updates Progress on Human Study #7

Biotech Investing
Lexaria Bioscience (NASDAQ:LEXX)

Lexaria Bioscience Launches Ongoing Investor Video Series to Expand Shareholder Communications

Biotech Investing
Lexaria Bioscience (NASDAQ:LEXX)

Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended

Biotech Investing
Lexaria Bioscience (NASDAQ:LEXX)

Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs

Biotech Investing
Lexaria Bioscience (NASDQ:LEXX)

Lexaria Bioscience:  Drug Delivery Platform Innovator with Multiple Mainstream Applications

Biotech Investing
Lexaria Bioscience (NASDAQ:LEXX)

Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales

Biotech Investing
Seegnal (TSXV:SEGN)

Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness

Pharmaceutical Investing
Lexaria Bioscience (Nasdaq:LEXX)

Lexaria's New Animal Study Aims to Expand Valuable Intellectual Property

Geography
Lexaria Bioscience (NASDAQ:LEXX)

Lexaria's New Animal Study Aims to Expand Valuable Intellectual Property

Biotech Investing
Lexaria Bioscience (NASDAQ:LEXX)

Lexaria Applauds Eli Lilly's Foundayo Drug Approval

Biotech Investing
International
Solvonis Therapeutics (LSE:SVNS)

Expansion of SVN-015 into Depression Following Positive Preclinical Data

Pharmaceutical Investing

Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

SmartNews
Cardiex Limited (ASX:CDX)

FY25 Preliminary Results Summary and Company Update

Geography
Cardiex Limited (ASX:CDX)

Appendix 4E

Geography
Radiopharm Theranostics (ASX:RAD)

Appendix 4E and Preliminary Final Report

Geography
More biotech News
Editors' Picks
Biotech Investing

Biotech Market Forecast: Top Trends for Biotech in 2026

Life Science Investing

Biotech and Pharma Market Update: Q3 2025 in Review

Life Science Investing

Biotech and Pharma Market Update: Q2 2025 in Review

Latest biotech News

More biotech News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES